WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jill DesimoneDirector2026-06-2410$301.44
$3.01kSell
Jill DesimoneDirector2026-06-24120$303.13
$36.38kSell
Jill DesimoneDirector2026-06-24320$305.31
$97.70kSell
Jill DesimoneDirector2026-06-241,004$312.83
$314.08kSell
Jill DesimoneDirector2026-06-24504$313.66
$158.09kSell
Jill DesimoneDirector2026-06-242,854$311.91
$890.20kSell
Jill DesimoneDirector2026-06-241,750$310.89
$544.06kSell
Jill DesimoneDirector2026-06-24999$309.38
$309.07kSell
Jill DesimoneDirector2026-06-241,240$308.24
$382.22kSell
Jill DesimoneDirector2026-06-24683$306.77
$209.52kSell

1 of 7

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP17.55%4,894,109$1.54BInsider
Janus Henderson Group PLC12.41%3,458,863$1.09BInstitution
Stefan Vitorovic10.54%2,939,329$924.15MInsider
Orbis Allan Gray Ltd8.87%2,472,480$777.37MInstitution
Holdings A. Novo8.76%2,442,080$767.81MInsider
Blackrock Inc8.34%2,324,929$730.98MInstitution
Fmr LLC7.75%2,160,943$679.42MInstitution
Adage Capital Management LP7.39%2,060,175$647.74MInsider
Perceptive Advisors LLC7.30%2,035,986$640.13MInstitution
Baker Bros Advisors LP6.29%1,753,198$551.22MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX69.37%30.63%Net SellingNet Buying
SYRE79.27%20.73%Net SellingNet Selling
PTGX84.37%15.63%Net SellingNet Selling
TGTX58.59%41.41%Net Selling
IONS96.89%3.11%Net SellingNet Selling
View Top Biotech Stocks

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 114.03% institutional shareholders, 50.35% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 17.55% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $1.49B.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.